Seaweed antioxidants show promise in preventing Parkinson’s disease

FHS
August 5, 2024
11:07 am

Parkinson’s disease is a neurodegenerative disease caused by the loss of neurons that produce dopamine, a neurotransmitter involved in motor control and cognitive function.

AI biotechs Recursion and Exscientia first held deal talks in 2022

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 11, 2024

Three major health care policy issues to watch in 2025

WASHINGTON — Health care did not play a big role in the election that’s sending President Trump back to the White House and giving Republicans

December 16, 2024

Satsuma’s nasal migraine candidate rejected by FDA over CMC issues

Satsuma Pharmaceuticals was handed a complete response letter for its nasal migraine drug after the agency found issues with the product’s chemistry, manufacturing and controls. No

January 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.